J&J Gets Second Chance At Sedasys Sedation Device Approval
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson subsidiary Ethicon Endo-Surgery has received a go-ahead from the FDA commissioner's office to embark on a rarely used process to appeal a PMA denial by the agency’s device center.